Supplemental material
Acta Oncologica
Volume 59, 2020 - Issue 1
Open access
3,098
Views
7
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES: MEDICAL ONCOLOGY
Neutropenic complications in the PANTHER phase III study of adjuvant tailored dose-dense chemotherapy in early breast cancer
Antroula PapakonstantinouDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; ;Breast Cancer, Endocrine Tumours and Sarcoma Section, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden; Correspondence[email protected]
View further author information
, View further author information
Elham HedayatiDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; ;Breast Cancer, Endocrine Tumours and Sarcoma Section, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden; View further author information
, Mats HellströmCKC, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden; View further author information
, Hemming JohanssonCKC, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden; View further author information
, Michael GnantDepartment of Surgery, Medical University of Vienna, Vienna, Austria; ;Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria; View further author information
, Günther StegerAustrian Breast and Colorectal Cancer Study Group, Vienna, Austria; ;Department of Medical Oncology, Medical University, Vienna, Austria; ;Gaston H. Glock Research Center, Medical University, Vienna, Austria; View further author information
, Richard GreilAustrian Breast and Colorectal Cancer Study Group, Vienna, Austria; ;III Medical Department, Cancer Cluster Salzburg, Salzburg Cancer Research Institute, Paracelsus Medical University Salzburg, Salzburg, Austria; View further author information
, Michael UntchDepartment of Obstetrics and Gynecology, Helios Klinikum Berlin-Buch, Berlin, Germany; View further author information
, Volker MoebusDepartment of Gynecology and Obstetrics, Klinikum Frankfurt Höchst, Academic Hospital of the Goethe University, Frankfurt, Germany; View further author information
, Sibylle LoiblGerman Breast Group, Neu-Isenburg, GermanyView further author information
, Theodoros FoukakisDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; ;Breast Cancer, Endocrine Tumours and Sarcoma Section, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden; View further author information
, Jonas BerghDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; ;Breast Cancer, Endocrine Tumours and Sarcoma Section, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden; View further author information
& Alexios MatikasDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; ;Breast Cancer, Endocrine Tumours and Sarcoma Section, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden; View further author information
show all
Pages 75-81
|
Received 23 Jun 2019, Accepted 16 Sep 2019, Published online: 04 Oct 2019
Related Research Data
Neutropenic complications in the PANTHER phase III study of adjuvant tailored dose-dense chemotherapy in early breast cancer
Source:
Taylor & Francis
Neutropenic complications in the PANTHER phase III study of adjuvant tailored dose-dense chemotherapy in early breast cancer
Source:
Taylor & Francis
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.